Novel Hybrid CHC from β-carboline and <i>N</i>-Hydroxyacrylamide Overcomes Drug-Resistant Hepatocellular Carcinoma by Promoting Apoptosis, DNA Damage, and Cell Cycle Arrest.

Front Pharmacol · 2020 · PMC7848139 · PMID 33536926

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

almost significantno p-value reported

Treatment with CHC at the same dosage showed an almost significant anti-tumor effect compared to the SAHA group, i.e., CHC exhibited a more significant decrease in tumor size after CHC treatment.

also in 1,858 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.